Overview

Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

Status:
COMPLETED
Trial end date:
2024-11-11
Target enrollment:
Participant gender:
Summary
This is a phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Integrative Research Laboratories AB